Everolimus EP Impurity E with CAS No: 1237826-25-3 is an impurity standard of Everolimus. Everolimus is an immunosuppressive medication used in transplant medicine and oncology. As an inhibitor of the mammalian target of rapamycin (mTOR), everolimus interferes with cell signaling pathways involved in the regulation of cell growth, proliferation, and angiogenesis. In transplant medicine, everolimus is often used in combination with other immunosuppressive drugs to prevent organ rejection in kidney and liver transplant recipients. In oncology, everolimus has been approved for the treatment of various cancers, including advanced kidney cancer, breast cancer, and certain types of neuroendocrine tumors. Buy high quality Everolimus EP Impurity E from Chemicea Pharmaceuticals. Chemicea Pharmaceuticals is one of the leading manufacturer and exporter of Everolimus EP Impurity E
Everolimus EP Impurity E
CAT. No.
CP-E33005
CAS. No.
1237826-25-3
Mol. F.
C52H79NO14
Mol. Wt.
942.2
Stock Status
Custom Synthesis
Category:
Impurity Standards
Synonyms:
42-O-Formyl Rapamycin
Chemical Name:
(1R,2R,4S)-4-[(2R)-2-[(1R,9S,12S,15R,16E,18R,19R,21R,23S,24E,26E,28E,30S,32S,35R)-1,18-dihydroxy-19,30-dimethoxy-15,17,21,23,29,35-hexamethyl-2,3,10,14,20-pentaoxo-11,36-dioxa-4-azatricyclo[30.3.1.04,9]hexatriaconta-16,24,26,28-tetraen-12-yl]propyl]-2-methoxycyclohexyl formate (as per EP)
Request for Quotation : Everolimus EP Impurity E
Thank You
We have received your request successfully. Thank you for your interest in our product line. To
provide you with a Quotation, Our Sales team will contact you shortly.
Thank You
You will receive blog content, featuring scientific research and exclusive promotions.